Previous studies have indicated that the activation of the noncanonical NF-κB pathway by NIK significantly enhances oncogenic signaling and high NIK activity is associated with different human malignancies and supports poor survival in tumor patients (62). This evidence concerns the gene NFKB1 and neoplasm.